HRAS and cancer: Finally, we show that blocking access to the fundamental ESE, located in HRAS c.34-39, using a splice switching oligonucleotide (SSOs), causes exon 2 skipping, abolishes production of functional HRAS protein and halts proliferation of cancer cells.